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The Type VI secretion system (T6SS) is important for bacterial competition as well as
virulence in many Gram-negative bacteria and its dynamics and regulation varies signiﬁcantly
between species. To gain insights into the mechanisms regulating T6SS assembly, we apply
targeted proteomics to determine the abundance of the key T6SS components in Vibrio
cholerae, Pseudomonas aeruginosa and Acinetobacter baylyi. We show that while there are
species speciﬁc exceptions, the abundance of most components is similar in all three bacteria
and ranges from less than hundred to tens of thousands of copies per cell. The comparison of
T6SS dynamics and protein abundance in V. cholerae grown under various conditions sug-
gests that the critical component TssE and the secreted protein VasX are unstable and this
diminishes T6SS assembly when protein synthesis is limited. Our quantitative analysis opens
possibilities to build realistic models of T6SS assembly and to identify principles of T6SS
regulation in various species.
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The Type VI secretion system (T6SS) is present in ~25% ofsequenced Gram-negative bacteria, including manypathogens where T6SS is often important for virulence1–5,
however, T6SS is also involved in bacterial interaction and
competition6–8. T6SS is composed of a cell envelope-associated
membrane complex, which spans both membranes and assembles
from TssJ, TssL, and TssM9–12. TssK connects the membrane
complex to the baseplate that consists of at least TssE, TssF, and
TssG13–15. VgrG/PAAR spike is in the center of the baseplate and
serves as a platform for initiation of the Hcp tube polymeriza-
tion2,14,15; while the TssB/TssC (also called VipA/VipB) sheath
assembles around the inner Hcp tube16–19. TssA is involved in
baseplate assembly and sheath–tube polymerization20–22, while in
some organisms, membrane-bound TagA prevents excessive
sheath polymerization which may destabilize the sheath23. Sheath
assembles by addition of soluble subunits at the end distal from
the baseplate and its length is correlated with the width of the
cell24. Upon unknown signal, the sheath undergoes rapid con-
traction, which propels the rigid inner tube with the effectors
associated with Hcp or VgrG/PAAR spike into the target
cells17,25. The disassembly of the contracted sheath is driven by
AAA+ ATPases such as ClpV or ClpB4,17,26–29.
Dynamics of T6SS assembly varies among species despite
conservation of key components. This is most likely due to dif-
ferent transcriptional or post-translational regulation among
bacteria, as well as presence and absence of accessory proteins.
For instance, in Pseudomonas aeruginosa, the activity of H1-
T6SS30 relies mostly on the posttranslational regulation. Phos-
phorylation of Fha by the serine–threonine kinase PpkA is
required for T6SS assembly, while the phosphatase PppA is
responsible for the Fha dephosphorylation31. A periplasmic
protein TagR and inner membrane complex TagS/TagT are
necessary for the activation of PpkA32,33. An outer membrane
protein, TagQ, likely tethers TagR to the outer membrane2,32,33.
In addition, H1-T6SS is negatively regulated by TagF indepen-
dently of Fha phosphorylation34. What activates this signaling
cascade is poorly understood, however, this pathway is required
for subcellular localization of T6SS assembly in response to T6SS
activity in the neighboring cell8. Furthermore, H1-T6SS can be
activated when cells are sensing membrane damage caused by
conjugation or membrane-targeting antibiotics, such as poly-
myxin B35, or chelation of outer membrane-bound cations
mediated by extracellular DNA or EDTA36.
It remains poorly understood how the initiation of T6SS
assembly is regulated among different species. In particular, the
abundance of most T6SS components in cells remains largely
unknown. This question may be addressable with targeted pro-
teomics approaches, such as selected reaction monitoring mass
spectrometry (SRM-MS). SRM is a highly sensitive and selective
quantitative approach to determine abundances of selected target
proteins with high precision and reproducibility37,38. It offers a
wide dynamic quantiﬁcation range starting from tens of copies to
106 copies per cell in yeast38 or over four orders of magnitude in
Mycobacterium tuberculosis39. Moreover, it allows consistent
monitoring of a set of proteins over multiple samples and to
determine absolute protein levels directly in samples when
combined with spiked-in heavy reference peptides40,41.
Here, we apply targeted proteomics using stable isotope dilu-
tion (SID) in combination with SRM-MS to quantify the protein
abundance of the known T6SS components in three organisms,
the H1-T6SS from P. aeruginosa PAO1, Vibrio cholerae 2740-80,
and Acinetobacter baylyi ADP1. Moreover, we determine the
abundance of the V. cholerae T6SS components under different
growth conditions and compare it with the dynamics of T6SS
assembly in live cells. The abundance of most components reﬂects
their function in all three bacteria, with as low as a few hundred
copies per cell for spike proteins and tens of thousands of copies
for sheath components. The comparison of T6SS protein abun-
dance in V. cholerae grown under various conditions suggests that
the baseplate component TssE and the secreted protein VasX are
unstable, which greatly reduces the T6SS assembly when protein
synthesis is limited.
Results
Quantiﬁcation of abundance of T6SS components. Most T6SSs
are assembled from 10 to 15 conserved structural components
including membrane complex and baseplate, as well as sheath/
tube (Fig. 1a). Despite the conservation of key components of
T6SS, this nanomachine exhibits strikingly diverse dynamics
among species. The H1-T6SS from P. aeruginosa is activated in
response to membrane perturbation (Fig. 1b); while cells of V.
cholerae constitutively assemble 3–5 structures that are dynami-
cally positioned within cells without any apparent localization
pattern (Fig. 1c). Similarly, A. baylyi ADP1 cells assemble 1–2
highly dynamic structures (Fig. 1d).
To get insights into the potential mechanisms of regulation of
T6SS assembly initiation, we ﬁrst determined the absolute copy
number of proteins in various bacteria grown under conditions
that allow for different levels of T6SS activity. We grew P.
aeruginosa PAO1 ΔretS, V. cholerae 2740-80, and A. baylyi ADP1
to different OD600 from 0.5 to 4.0. We counted the bacteria in
these cultures using ﬂow cytometry (Supplementary Table 1). The
whole cell lysates were then prepared from known number of
cells and protein concentrations were measured using BCA assay
(Thermo Fisher). This allowed us to estimate that total protein
amount is ~280 fg/cell for P. aeruginosa with an OD600 1.2–1.5,
156–260 fg/cell for V. cholerae with an OD600 0.5–4.0, and 210 fg/
cell A. baylyi with an OD600 0.8–1.2 (Supplementary Table 1).
This is consistent with estimated protein concentrations in the
range of 200–300mg/ml42 and volume of a typical bacterial cell of
~1 µm3. These measured values were then used to estimate the
number of cells across all cell lysates grown to similar OD600 by
measuring concentration of total proteins in each sample. The
errors of such estimations come from both cell number count by
FACS and protein content determination by BCA and are 5.02%,
7.45%, and 7.34% among triplicates for P. aeruginosa, V. cholerae,
and A. baylyi, respectively. To minimize additional errors
introduced during sample preparation, we used a recently
established protocol that demonstrated highly efﬁcient and
reproducible protein extraction and digestion from bacterial cells,
in particular for membrane proteins43.
We then applied SID-SRM-MS using the combination of
stable-isotope-labeled peptide pools and precisely quantiﬁed light
peptides (JPT peptides) to quantify all the structural proteins, as
well as regulatory components in all three bacteria (Fig. 2a,
Supplementary Data 1, see the section “Methods” for details). For
60 out of 66 proteins, copy numbers were determined from two
independent peptide measurements (Supplementary Data 1). For
determination of peptide concentrations in the heavy peptide
pool, 123 out of 126 selected peptides displayed <30% coefﬁcient
variation during MS analysis (Supplementary Data 1). Moreover,
in this set of assays, the measurement of 121 out of 126 peptides
displayed <20% variation across three biological replicates
(Supplementary Data 1), indicating that the measurements were
highly reproducible.
Overall, our results show that abundance of T6SS components
range from 10 to 105 copies per cell (Fig. 2b–d). The abundance
of TssB (VipA), TssC (VipB), and ClpV in V. cholerae (Fig. 2c)
were approximately 25,000, 15,500, and 3100, respectively, which
is in a reasonable agreement with the previously reported
copy number 27,000, 26,000, and 3500, respectively, estimated
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by semi-quantitative immunoblotting26. In addition, comparison
of the abundance of T6SS components in P. aeruginosa
expressing or lacking RetS shows that most proteins except TagS
and VgrG1c are about 2–6-fold more abundant in RetS-negative
strain (Supplementary Fig. 1; Supplementary Data 6), which is in
agreement with previously observed retS-dependent regulation of
transcription30,44.
Abundance mostly correlates with the stoichiometry of T6SS.
The current model of T6SS assembly predicts certain stoichio-
metry for T6SS components. A single T6SS structure is composed
of a single PAAR protein, three VgrG proteins, 5–12 copies of
components forming membrane and baseplate complex, however
up to thousand copies of Hcp and TssB/TssC10,14,16,25,45. Indeed,
for all three analyzed bacteria, sheath proteins (TssB and TssC)
were highly abundant (in the range of 104 copies per cell). By
contrast, spike proteins, such as PAAR or VgrGs were among the
least abundant components, suggesting that availability of these
proteins could be limiting the number of T6SS assemblies per cell.
Baseplate components were in the range of 102–103 copies/cell;
while membrane components were in the range of 1–2 × 103
copies/cell. Interestingly, in all three organisms, the components
of the membrane complex were more abundant than components
of the baseplate (Supplementary Data 1; Fig. 2b–d).
Overall, the relative protein abundance was conserved among
all three bacteria, however, some signiﬁcant differences were
observed. For instance, in P. aeruginosa, Fha1 had low
abundance, while the homolog in V. cholerae is almost four
times more abundant (1500 copies and 7000 copies per cell in
P. aeruginosa and V. cholerae, respectively). While Fha has been
shown to be essential for the assembly of T6SS in V. cholerae, its
function remains unclear46.
We included the species-speciﬁc accessory components in our
analysis to get insights into their possible roles in T6SS assembly.
The post-translational modiﬁcation of Fha1 by TagQRST-PpkA
pathway is required for assembly of H1-T6SS in P. aeruginosa.
TagR/TagS/TagT as well as PpkA/PppA/Fha were detected in the
range of 102–103 copies per cell (Supplementary Data 1).
Strikingly, TagQ, which is the outer membrane protein, was the
most abundant component (~61,000 copies per cell), while TagR,
which binds TagQ, is present only in ~1000 copies per cell. TagS
(~200 copies) and TagT (~400 copies) are present at very low
copy number, at least seven times less than components of the
membrane complex.
Several components of A. baylyi ADP1 T6SS have currently
unknown function, in particular ACIAD2685, ACIAD2693, and
ACIAD2698. While ACIAD2693 and ACIAD2698 were found to
be dispensable for T6SS function, ACIAD2685 is required for
efﬁcient T6SS assembly initiation47. Interestingly, ACIAD2685 is
present in only about 800 copies per cell. This is similar to
another protein TagX (~350 copies), which is predicted to be an
enzyme that cleaves peptidoglycan48 likely to initiate membrane
complex assembly similarly to what was shown for MltE, a
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Fig. 1 The various T6SS dynamics in different bacteria. a The overall structure of T6SS adapted from Nazarov et. al.14. b Time-lapse imaging of H1-T6SS
dynamics in cells of P. aeruginosa PAO1 (ΔretS background). The most left panel shows a merged image of phase contrast and GFP channel (ClpV-GFP); the
other panels show the time-lapse series of GFP channel (ClpV-GFP) in an interval of 10 s. c Time-lapse imaging of T6SS dynamics in cells of V. cholerae
2740-80. The most left panel shows a merged image of phase contrast and GFP channel (TssB-msfGFP); the other panels show the time-lapse series of
GFP channel (TssB-msfGFP) in an interval of 10 s. d Time-lapse imaging of T6SS dynamics in cells of A. baylyi ADP1. The most left panel shows a merged
image of phase contrast and GFP channel (TssB-sfGFP); the other panels show the time-lapse series of GFP channel (TssB-sfGFP) in an interval of 10 s.
Scale bar: 2 µm
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transglycosylase in enteroaggregative E. coli49. Together with very
low copy number of certain VgrGs and PAAR protein,
ACIAD2685 and TagX could be involved in regulation of the
frequency of T6SS assembly.
Change of abundance in response to growth phase. We tested if
changes in T6SS activity correlate with changes in protein
abundance under varying growth conditions. The observed
number of T6SS assemblies per cell increases in V. cholerae with
OD600 from ~0.6 with ~1 structure per cell on average to early
stationary phase (OD600 1.2–1.5) with 2.58 structures per cell on
average. It is worth noting that when the T6SS assembly is high in
the cell (above three per cell), measured number of sheath
assemblies is likely an underrepresentation of the actual number
of sheath assemblies in the cell, as many sheaths would not be
resolved using conventional light microscopy. Therefore, it is
likely that more than three structures assembled on average at
OD600 1.2–1.5. Such high T6SS activity is maintained till
OD600~2. When cells grow to OD600 above 2, the number of T6SS
assemblies decreases to about 1 sheath structure per cell. More-
over, at OD600 above 4, cells become signiﬁcantly smaller and the
T6SS is mostly inactive (Fig. 3a; Supplementary Movie 1).
We applied the SID-SRM-MS to samples collected from four
representative growth stages (OD600~0.8, OD600~1.2, OD600~4,
and OD600~5). By calculating the copy number per cell as
explained above and normalizing to the most active stage of T6SS
(Supplementary Data 2, OD600~1.2), we compared the protein
abundances for all measured T6SS components (Supplementary
Data 2; Fig. 3b). When cells transitioned from early exponential
phase (OD600~0.7) to late exponential or early stationary phase
(OD600~1.2), concentrations of membrane complex components,
as well as TssB and TssC remained unchanged or slightly
increased. Notably, during this transition, all baseplate compo-
nents as well as Hcp showed slight decrease in abundance
(Fig. 3b). Interestingly, spike proteins (PAAR and VgrGs),
especially VgrG2 showed a striking increase in abundance
(Supplementary Fig. 2; ~50%; p ≤ 0.01, Tukey’s multiple compar-
isons test used for all comparisons) when cells grew from early to
late exponential phase; while protein levels of PAAR increased by
35% (Fig. 3b; Supplementary Fig. 2; p ≤ 0.01). This correlated with
the increase of the number of sheath assemblies observed by live-
cell imaging (Fig. 3a; Supplementary Movie 1). Levels of most
proteins remained unchanged during this transition; Fha
exhibited a slight increase, while VasH and TagA showed a
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Fig. 2 Abundance of T6SS components in different bacteria. a The overall experimental procedure for determining the abundance of proteins in this work.
b The absolute copy number of each selected component of H1-T6SS in whole cell lysate of P. aeruginosa PAO1 (ΔretS background) grown to OD600 1.2–1.5.
c The absolute copy number of each selected component of T6SS in whole cell lysate of wild-type V. cholerae 2740–80 grown to OD600 1.2–1.5. d The
absolute copy number of each selected component of T6SS in whole cell lysate of wild-type A. baylyi ADP1 grown to OD600 1.2–1.5. b–d The quantiﬁcation
of heavy peptides from the peptide mixes were determined using corresponding light quantiﬁed peptides in triplicates. All abundance measurements were
performed in three independent biological experiments. Bar graph shows the average of copy number determined by two peptides (individual
measurements shown with dots for peptide 1 or triangles for peptide 2), with error bar as the SD between measurements from both peptides if available;
otherwise, SD between biological replicates is shown (highlighted with a star). Note the y‐axis is in Log10 scale. All measurements are available in
Supplementary Data 1. Source data are provided as a Source Data ﬁle
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slight decrease (Fig. 3b; p ≤ 0.05). Interestingly, the level of an
effector protein VasX also increased signiﬁcantly during this
phase (Supplementary Fig. 2; 50%; p ≤ 0.001).
After the OD600 increased to ~4, all components showed
signiﬁcant decrease in their abundance. In particular, TssE and
VasX decreased by 85% (Supplementary Fig. 2; p ≤ 0.01 and p ≤
0.0001, respectively); while VgrG2, VgrG3, and PAAR decreased
by ~70% (Supplementary Fig. 2; p ≤ 0.05). Overall, the change
observed in the protein levels was in good agreement with live-
cell imaging (Fig. 3a; Supplementary Movie 1). In addition to the
core components, we also analyzed the change in relative
abundance for effector and immunity proteins (Supplementary
Fig. 4A) and, with the exception of TsiV3, we observed a similar
trend of change as for the structural or regulatory components of
T6SS.
Change of abundance upon protein synthesis inhibition. To
determine mechanisms responsible for decrease of T6SS activity
when expression is downregulated, we analyzed the abundance of
T6SS components of V. cholerae exposed to a high dose of
chloramphenicol (1 mg/ml). We examined the morphology of
cells after up to 90 min treatment and observed that most cells
remained intact (Supplementary Fig. 7). Within 20 min of the
protein synthesis inhibition, we observed a dramatic decrease in
T6SS activities (from more than 2.3 structures per cell before
treatment to only 1 structure per cell). Forty-ﬁve minutes after the
treatment, only 1 structure can be observed in 5 cells on average.
Ninety minutes after the treatment, T6SS assembly was almost
completely abolished (Fig. 4a; Supplementary Movie 2). Since we
observed no signiﬁcant decrease of TssB-sfGFP signal by live-cell
imaging, we ﬁrst normalized the abundance of all components to
TssB and then compared these to the levels measured before
chloramphenicol treatment (Supplementary Data 3; Fig. 4b).
Interestingly, within only 20 min after chloramphenicol treat-
ment, we observed 70% decrease in the abundance of TssE
(Supplementary Fig. 3; p < 0.0001, one‐way ANOVA with multi-
ple comparison using Tukey correction), as well as smaller
decrease of abundance of other baseplate components (Fig. 4b;
Supplementary Fig. 3). Ninety minutes after the treatment, TssE
abundance dropped below 10%. By contrast, abundance of
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error bar represents the standard deviation of measurements (n= 3 biologically independent samples). Plots were grouped into four subsets: spike
proteins, baseplate/membrane complex, sheath/tube proteins, and other components. Individual plots are shown in Supplementary Fig. 2. The detailed
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membrane components remained largely unchanged throughout
the treatment (Fig. 4b). The secreted components such as Hcp,
VgrG3, and VgrG2, as well as PAAR exhibited a gradual decrease
during the treatment (Fig. 4b). TssC, TagA, TssA, VasI, ClpV,
and Fha decreased <15% after 90-min treatment, but VasH
decreased by more than 30% (Fig. 4b). We also compared the
relative abundance of effector and immunity proteins following
the protein synthesis inhibition (Supplementary Fig. 4B). Like
most T6SS components, these proteins remain relatively stable
after the treatment with an exception of TsiV1 and Tap1.
Interestingly, abundance of the effector VasX decreased by 60%
within 20 min of the treatment (Supplementary Fig. 3; p <
0.0001). Overall, VasX and TssE showed the fastest and highest
decrease in protein abundance after protein synthesis inhibition.
This is similar to what was observed during the transition from
exponential to stationary phase (Fig. 3b).
To test the stability of TssE and VasX in the absence of other
V. cholerae proteins, we overexpressed tssE or vasX in E. coli from
the pBAD24 vector. We then exposed these cells to the same high
dose of chloramphenicol and quantiﬁed the abundance of TssE or
VasX by SRM-MS analysis. Within 90 min of the treatment, we
observed decrease of TssE by ~75% and VasX by 85%
(Supplementary Fig. 5; Supplementary Data 7). This suggests
that both proteins are generally unstable, however, it is unclear
how these proteins are degraded in V. cholerae or E. coli.
TssE and VasX are together essential for the T6SS assembly.
TssE is considered to be an important baseplate component,
which might anchor T6SS sheath to the baseplate18,50. VasX, on
the other hand, is a membrane-disrupting effector secreted by
T6SS in V. cholerae51–54. In the absence of tssE, T6SS activity is
largely decreased as shown by live-cell imaging of TssB-msfGFP
dynamics, however, not completely abolished (Fig. 5a; Supple-
mentary Movies 3 and 4), similarly to what was shown
before17,53. Cells lacking vasX assemble less T6SS during both
exponential phase and early stationary phase (Fig. 5a; Supple-
mentary Movies 3 and 4). However, in cells lacking both tssE and
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provided as a Source Data ﬁle
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vasX, the T6SS assembly is abolished (Fig. 5a; Supplementary
Movies 3 and 4). By contrast, cells lacking TssE and either one of
effectors VgrG1, VgrG3, or TseL still assemble T6SS with a
similar frequency (Supplementary Fig. 6 and Supplementary
Movie 6). The ectopic expression of tssE from an arabinose-
inducible promoter in ΔtssE/ΔvasX background restored T6SS
activity to the level observed in ΔvasX strain, while ectopic
expression of vasX increased frequency of T6SS assembly to the
level observed in ΔtssE strain (Fig. 5b; Supplementary Movie 5),
ruling out possible polar effects of the introduced mutations.
Discussion
In this work, we applied a targeted proteomic approach to
quantify the protein abundance of the known T6SS components
from three organisms with distinct dynamics of T6SS (Fig. 2). The
SID-SRM-MS method allowed us to measure the abundance of
the selected components with high precision (median CV of
16.51% between peptide measurements for the same protein,
median CV of 8.63% among biological triplicates). While absolute
quantiﬁcation of protein abundance per cell has several possible
sources of error, mostly cell size variation and protein extraction
and digestion efﬁciency, the relative comparison of protein
amount and careful calibration of individual steps allow for
precise determination of changes in protein abundance under
various conditions. Compared to antibody-based quantiﬁcation,
this approach requires no speciﬁc antibody and production of
recombinant proteins for calibration of immuno-detection. After
initial identiﬁcation of appropriate peptides, the method is fast
and easily scalable to parallel analysis of tens of proteins of
interest. Therefore, we believe that targeted proteomics could
replace the standard immuno-detection-based approaches used to
date to study regulation of T6SS assembly.
We observed a direct correlation between protein levels and
their roles in the assembly and dynamics of T6SS. For instance,
the membrane complex, spike, and baseplate components are
known to be present in 1–12 copies per T6SS assembly10,14 and
were indeed among the least abundant components in all three
analyzed organisms. By contrast, we detected a large number of
TssB/TssC and Hcp, which assemble into long polymers with
more than thousand copies per single T6SS16,18. However, several
accessory T6SS proteins are less understood and thus quantiﬁ-
cation of their abundance might help deciphering their roles in
T6SS assembly. For example, activation of H1-T6SS of P. aeru-
ginosa requires phosphorylation of Fha1 protein by inner-
membrane kinase PpkA, which is presumably activated by
binding of periplasmic protein TagR31,33. It was suggested that
TagR is bound to an outer-membrane protein TagQ32. Interest-
ingly, we show here that TagQ is highly abundant in
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Fig. 5 TssE and VasX contribute to the regulation of T6SS assembly. a The sheath assembly was monitored by TssB-msfGFP localization in the absence of
TssE, VasX, or both. Representative images of GFP channel are shown for each indicated strain (all tssB-msfGFP background). The upper panel shows the
cells grown to OD600 0.6; the lower panel shows the cells grown to OD600 1.5. The average number of sheaths is indicated below each image. Time-lapse
movies with a larger ﬁeld of view can be found in Supplementary Movies 3 and 4. b The sheath assembly was monitored by TssB-msfGFP localization with
either tssE or vasX expressed under arabinose promoter in tssB-msfGFP strains lacking both tssE and vasX. The average number of sheaths is indicated below
each image. Scale bar: 5 µm. Time-lapse movies with a larger ﬁeld of view can be found in Supplementary Movie 5. Source data are provided as a Source
Data ﬁle
NATURE COMMUNICATIONS | https://doi.org/10.1038/s41467-019-10466-9 ARTICLE
NATURE COMMUNICATIONS |         (2019) 10:2584 | https://doi.org/10.1038/s41467-019-10466-9 | www.nature.com/naturecommunications 7
P. aeruginosa and is present in about 60-fold higher copy number
than TagR. This could be necessary for efﬁcient recruitment of
TagR away from PpkA to prevent futile T6SS assembly, however,
TagR is itself required for PpkA activation33. TagS and TagT,
which is predicted to be an ATP-binding component of an ABC
transporter32, are present at about 7× lower copy number than
the components of the membrane complex, suggesting that it is
the enzymatic activity rather than the structure of TagST that
plays an important role in T6SS activation.
Any complex biological system requires a precise and coordi-
nated assembly of its components. The insights into mechanisms
of T6SS assembly were so far mostly based on imaging of the
individual components in live cells, mutagenesis, protein–protein
interaction studies, and structural biology2,55–57. While these
approaches provided critical insights, we have almost no infor-
mation about how the copy number of the individual components
change under various conditions and how would such changes be
reﬂected in T6SS assembly. For example, it has been demon-
strated that manipulating the level of tube protein Hcp led to the
change of the length of sheath in V. cholerae, while limiting spike
protein VgrG2 resulted in the reduction of the number of T6SS
assemblies53. T6SS regulation was studied by analysis of RNA
expression levels under various conditions58–60, however, the
mRNA abundance is often not strictly correlated with protein
levels for many proteins61, which may limit insights that such
studies provide into T6SS assembly.
Here, we analyzed changes in abundance of T6SS components
under conditions that signiﬁcantly change frequency of T6SS
assembly. Abundance of most T6SS components was changing
similarly during various stages of growth of V. cholerae or when
protein synthesis was inhibited by chloramphenicol. Transition
from early to late exponential phase resulted in higher copy
number of nearly all T6SS components, which correlated well
with observed higher frequency of T6SS assembly. On the other
hand, during transition to late stationary phase or during chlor-
amphenicol treatment most components decreased in abundance
but that was unlikely to explain the up to 500-fold decrease in
frequency of T6SS assembly observed by live-cell imaging.
Importantly, abundance of certain T6SS components varied more
signiﬁcantly. Most notably, the abundance of baseplate protein
TssE and an effector VasX rapidly dropped under both condi-
tions. As shown previously53 and here, cells lacking TssE or VasX
assemble less T6SS. Interestingly, cells without both VasX and
TssE assemble no T6SS (Fig. 5), however, cells lacking TssE and
either one of the secreted substrates VgrG1, VgrG3, or TseL still
assemble T6SS sheath with the frequency comparable to the cells
lacking only TssE (Supplementary Fig. 6). This suggests that the
role that VasX plays in T6SS assembly in the absence of TssE is
unique because previous detailed analysis of sheath assembly in
V. cholerae showed that deletion of vgrG3 resulted in higher
decrease in sheath assembly frequency than deletion of vgrG1 or
vasX53. In the absence of structural information about VasX, we
can only speculate how VasX could compensate for the loss of
TssE, which is predicted to be a critical component of T6SS
connecting sheath to the baseplate18. It is possible that assembly
of VasX on the VgrG spike prevents assembly of a baseplate
containing TssE and that VasX itself could play a role of such a
connector protein.
The rapid decrease of TssE and VasX abundance cannot be
explained by protein dilution during cell growth and therefore it
raises additional questions about this process. While VasX is a
secreted protein, its abundance decreased faster than that of other
secreted spike components, such as VgrG or PAAR. Moreover,
ectopically expressed TssE or VasX also quickly disappeared from
the cytosol of E. coli upon inhibition of protein synthesis. Since
the amount of TssE and VasX diminished so quickly in both
V. cholerae and E. coli, we speculate that these proteins evolved to
be unstable and undergo proteolysis. A recent work has shown
that an effector TseT secreted by H2-T6SS of P. aeruginosa
requires its associated PAAR and/or chaperone protein TceT for
stability, while the stability of TceT requires the co-chaperone co-
TceT62. Interestingly, a chaperone VasW is required for secretion
but not for stability of VasX54. It remains to be tested how TssE
and VasX are degraded and what triggers their degradation. Since
lack of TssE almost completely abolishes T6SS assembly, protein
instability could be a general mechanism, which evolved to
quickly stop T6SS activity to save energy when resources are
limited, while preserving all the other T6SS components for
later time.
In conclusion, our work not only provides insights into the
abundance of different components of a complex bacterial
nanomachine in different bacteria, but also serves as an example
of a systematic study of the temporal changes of many proteins in
parallel. We show that the targeted proteomics together with live-
cell imaging is a powerful tool for expanding our knowledge
about mechanisms behind regulation of T6SS assembly.
Methods
Bacterial strains and growth. A list of strains used in this work can be found in
Supplementary Table 2. In general, bacterial cells were grown in Luria-Bertani (LB)
media at 37 °C for P. aeruginosa and V. cholerae, and 30 °C for A. baylyi ADP1.
Antibiotic concentrations used were ampicillin (300 µg/ml), streptomycin (100 µg/
ml) for V. cholerae, and 50 µg/ml for A. baylyi ADP1, Irgasan (20 µg/ml), and
chloramphenicol (20 µg/ml) for growth.
Construction of mutations in V. cholerae. In-frame deletion mutants of V. cho-
lerae were constructed by allelic exchange method using a suicide vector pWM91
as previously described63 in a tssB-msfGFP background18. For constructing plas-
mids used in complementation experiments, target genes were cloned into L-ara-
binose inducible vectors pBAD24 or pBAD3364. All cloning constructs were
veriﬁed by colony PCR and sequencing. A list of oligonucleotides designed in this
work can be found in Supplementary Table 3.
Live-cell imaging. For P. aeruginosa, overnight bacterial cultures of either ΔretS30
or WT65 were diluted 1:50 in fresh LB medium and cultivated at 37 °C to an OD600
of ~1.2–1.5. For A. baylyi ADP1, overnight bacterial cultures were diluted 1:50 in
fresh LB medium and cultivated at 30 °C to an OD600 of ~1.2–1.5. For V. cholerae,
overnight bacterial cultures were diluted 1:200 in fresh LB medium and cultivated
to desired OD600. For the complementation experiments from pBAD vectors, the
expression was induced by diluting overnight cultures 1:250 in fresh LB medium
supplemented with antibiotics, as well as 0.03% L-arabinose and cultivated at 37 °C
to an OD600 of ~1.2–1.5. One milliliter of cells were concentrated 10 times before
spotted onto a thin pad containing 1% LB and covered with a coverslip. Bacterial
cells were imaged as described47,53. The Nikon Ti-E inverted motorized microscope
used in this work was equipped with Perfect Focus System and Plan Apo 1003 Oil
Ph3 DM (NA 1.4) objective lens, SPECTRA X light engine (Lumencor), along with
ET-ECFP (Chroma #49001), ET-GFP (Chroma #49002), and ET-mCherry
(Chroma #49008) ﬁlter set for ﬂuorescence excitation and ﬁltration. sCMOS
camera pco.edge 4.2 with pixel size of 65 nm (PCO) and VisiView software
(Visitron Systems) were used for imaging. Humidity was set to 95% regulated by
Okolab T-unit (Okolab). Imaging for different bacteria was set at the desired
growth temperature. The duration and intervals of imaging were indicated in
ﬁgures. The image analysis was conducted in Fiji66 and customized plugin based on
StackReg67. The quantiﬁcation of sheath number in the cell was conducted in Fiji.
The total cell number was accessed from the phase contrast image using “Find
Maxima” with “edge maxima exclusion” function activated. The noise tolerance
setting was adjusted manually for each case. The number of sheath was counted
from the corresponding GFP image using “Find Maxima” with “edge maxima
exclusion” function activated. The noise tolerance setting was adjusted manually
for each case. At least 1000 cells were analyzed for each strain.
Time course of V. cholerae growth. Overnight bacterial cultures of strain B625
(V. cholerae tssB-msfGFP) were diluted 1:200 in fresh LB medium and cultivated to
different OD600 as indicated in the results. For each time point, ~109 cells were
harvested for the sample preparation for mass spectrometry, and another 1 ml of
cells suspension was concentrated for live-cell imaging. Three independent repli-
cates were analyzed.
Chloramphenicol treatment of V. cholerae. Overnight bacterial cultures of strain
B625 (V. cholerae tssB-msfGFP) were diluted 1:200 in fresh LB medium and
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cultivated to an OD600 of ~1.2–1.5. Chloramphenicol was added to the cultures to a
ﬁnal concentration of 1 mg/ml. 0, 20, 45, and 90 min after the treatment, ~109 cells
were harvested for the sample preparation for mass spectrometry, with another 1
ml of cells were concentrated for live-cell imaging. Three independent replicates
were performed.
Chloramphenicol treatment of E. coli. Overnight bacterial cultures of strains B348
(E. coli pBAD24-tssE) or LLB397 (E. coli pBAD24-vasX) were diluted 1:100 in fresh
LB medium supplemented with ampicillin and 0.003% and 0.03% of arabinose for
induction, respectively. Cultures were then cultivated to an OD600 of ~1.2–1.5.
Chloramphenicol was added to the cultures to a ﬁnal concentration of 1 mg/ml.
0 and 90 min after the treatment, ~109 cells were harvested for the sample pre-
paration for mass spectrometry. Three independent replicates were analyzed.
Sample preparation for mass spectrometry. Bacterial cultures grown at desired
OD600 were prepared as described for live-cell imaging. Pellets of ~109 cells were
washed three times with PBS at 4 °C and 8000 × g for 10 min in a table top cen-
trifuge. Cell pellets were then dissolved in lysis buffer (1% sodium-deoxycholate
(SOC) in 100 mM ammoniumbicarbonate) followed by the addition of 10 mM tris‐
2‐carboxyethyl‐phosphine (TCEP) to enable good extraction of proteins from
bacterial cells43. Samples were sonicated using VialTweeter (Hielscher), followed by
an incubation at 95 °C for 10 min. Samples were then subjected to the sonication
with 30 s on and 30 s off for 10–20 cycles using Bioruptor (Diagenode) until
samples became clear. After the complete lysis, the protein content was measured
by BCA assay for each sample (Pierce, Fisher Scientiﬁc). 15 mM of chloroacetamide
(Sigma) was added to the sample and incubated at 25 °C for 30 min with gentle
agitation. Lysyl-endopeptidase (Wako Diagnostics) was added to lysates of 100 μg
of proteins in a ﬁnal enzyme/protein ratio of 1:200 (w/w). The mixtures were then
incubated at 37 °C for 4 h. Peptides were then subjected to the digestion by trypsin
in a ﬁnal enzyme/protein ratio of 1:50 (w/w) for 12 h at 37 °C. 5% of triﬂuoroacetic
acid was added to a ﬁnal concentration of 1%. The precipitates were removed by
centrifugation while the supernatants were subjected to C18 solid phase extraction
using Macrospin columns (Harvard Apparatus). The eluted peptides were dried at
55 °C under vacuum and then resuspended in a buffer containing 0.15% formic
acid and 2% acetonitrile. The resuspensions were fully dissolved by using 10 s of
ultrasonication and 5 min incubation at 25 °C. Two C-terminally stable isotope-
labeled proteotypic peptide mixtures (SpikeMix L, JPT peptides) were added to
each sample. For each protein of interest, up to ﬁve peptides were included in the
pools. To select stable isotope-labeled proteotypic peptide suitable for the SRM, the
whole-cell preparation from each organism were analyzed by shotgun proteomics
ﬁrst. Peptides from the whole-cell samples were prepared as described above and
cleaned up using SP3 protocol with minor modiﬁcation68. Only peptides that were
unique for proteins of interest and detected signiﬁcantly by shotgun proteomic
LC–MS analysis were included for the synthesis. In general, for each sample, 15 μl
of peptides from biological samples containing ~7.5 μg of peptides were mixed with
5 μl of ~0.2 pmol of SpikeMix (the exact concentration of each isotope-labeled
peptide was determined as described below). The list of peptides included in both
SpikeMix L mixtures employed can be found in Supplementary Data 4. The
peptides in these mixtures were isotopically labeled at the C-terminus with either
heavy lysine or arginine acid. Both SpikeMix mixtures were dissolved in a buffer
containing 20% acetonitrile and 0.1% of triﬂuoroacetic acid. The samples were
ﬁnally subjected to SRM analysis in a TSQ Vantage mass spectrometer (Thermo
Scientiﬁc). Each sample was prepared and analyzed in biological triplicate. To
avoid peptide losses through hydrophobic interactions with plastic surfaces, only
low binding tips, tubes or glass vials were used when handling peptide standard
solutions.
Cell enumeration by FACS. The Bacteria Counting Kit (Thermo Fischer) was used
to enumerate bacteria by ﬂow cytometry according to manufacturer protocol with
minor modiﬁcation. Cells grown at desired OD600 were prepared as described
above and diluted with ﬁlter-sterilized 5% LB, 0.15 M NaCl to a ﬁnal density of
~106 cells/ml for further analysis. For each 1 ml of sample, 1 μl of SYTO BC
bacteria stain was added and incubated at room temperature in the dark for at least
5 min. Meanwhile, the microsphere standard suspension containing 108 beads/ml
was fully resuspended and sonicated in a water bath for 5 min. Ten microliters
of such suspension was added to the stained cells to have a ﬁnal concentration
of 106 beads/ml. The stained mixtures were subjected to the analysis in a ﬂow
cytometer (BD Bioscience) equipped with ex488-LP502-BP530/30 laser. The
estimation of cells number in the 1 ml sample was as following: The number of
cells/1 OD600/ml= the number of counting in the bacteria frame/the number of
counting in the microsphere frame × 106 × dilution factor/measured OD600 value.
Three replicates were performed for each condition, for example data and our
gating strategy (see Supplementary Fig. 8).
The protein content per cell for each bacterial species was estimated as
following: a complete extraction of protein contents from known number of cells
for each bacteria was performed as described above. The total protein contents
were measured by BCA assay (Pierce, Fisher Scientiﬁc). The total protein content
divided by the cell number provides the protein content per each cell. Three
replicates were performed. For all SRM analyses, the number of cells where native
peptides were extracted from was estimated using the following formula: number of
cells= peptide concentration × volume of sample/protein content per cell.
Determination of peptide concentration in SpikeMix. In total, 130 peptides that
displayed good qualities from SRM measurement were selected for further
synthesis of quantiﬁed, proteotypic peptides that have a C-terminal tag that can be
cleaved by tryptic digestion (SpikeTides™_TQ; the list can be found in Supple-
mentary Data 5). One hundred and twenty-nine out of them could be synthesized
with the desired quality. The synthesized peptides were then dissolved to a ﬁnal
concentration of 10 pmol/μl) in a buffer containing 20% acetonitrile and 0.1% of
triﬂuoroacetic acid. 100 pmol per quantiﬁed peptide were mixed and dried under a
vacuum at 55 °C. The dried peptide mixture was then dissolved in a buffer con-
taining 1M urea and 0.1 M ammoniumbicarbonate, and subjected to ultra-
sonication for 10 s, followed by 10 min incubation at 25 °C. The mixture was then
digested with trypsin for 12 h at 37 °C. The digested product was then acidiﬁed
with a ﬁnal concentration of 1% triﬂuoroacetic acid. The two isotope-labeled
peptide mixtures with ~100 pmol per each peptide were mixed with the digested
light quantiﬁed peptides and subjected to C18 solid phase extraction. After elution,
the peptides were dried under vacuum at 55 °C. The dried mixtures were then
dissolved in a buffer containing 0.15% formic acid and 2% acetonitrile. The
resuspensions were fully dissolved by using 10 s of ultrasonication and 5-min
incubation at 25 °C. The samples were diluted with 0.1% formic acid to a ﬁnal
concentration of 250 fmol/µl/peptide. 2 µl of this solution was injected into
the LC–MS instrument for SID-SRM-MS analysis. To avoid peptide losses
through hydrophobic interactions with plastic surfaces, only low binding tips,
tubes, or glass vials were used when handling peptide standard solutions. The
samples were subjected to SID-SRM-MS analysis to determine the precise con-
centrations of all selected heavy peptides. All samples were prepared and analyzed
in triplicates.
SRM LC–MS analysis. In the ﬁrst step, SRM assays69 were generated from a
mixture containing ~500 fmol of each heavy reference peptide (mixture of both
SpikeMix L mixes), as well as iRT peptides70 and shotgun LC–MS/MS analysis on a
Q-Exactive HF platform. The setup of the μRPLC–MS system was as described
previously71. Chromatographic separation of peptides was carried out using an
EASY nano-LC 1000 system (Thermo Fisher Scientiﬁc), equipped with a heated
RP-HPLC column (75 μm× 37 cm) packed in-house with 1.9 μm C18 resin
(Reprosil-AQ Pur, Dr. Maisch). Peptides were analyzed per LC–MS/MS run using
a linear gradient ranging from 95% solvent A (0.1% formic acid) and 5% solvent B
(99.9% acetonitrile, 0.1% formic acid) to 45% solvent B over 60 min at a ﬂow rate of
200 nl/min. Mass spectrometry analysis was performed on Q-Exactive HF mass
spectrometer equipped with a nanoelectrospray ion source (both Thermo Fisher
Scientiﬁc). Each MS1 scan was followed by high-collision-dissociation (HCD) of
the 10 most abundant precursor ions with dynamic exclusion for 20 s. Total cycle
time was ~1 s. For MS1, 3e6 ions were accumulated in the Orbitrap cell over a
maximum time of 100 ms and scanned at a resolution of 120,000 FWHM (at
200m/z). MS2 scans were acquired at a target setting of 1e5 ions, accumulation
time of 50 ms and a resolution of 30,000 FWHM (at 200m/z). Singly charged ions
and ions with unassigned charge state were excluded from triggering MS2 events.
The normalized collision energy was set to 27%, the mass isolation window was set
to 1.4m/z and one microscan was acquired for each spectrum. The acquired raw-
ﬁles were searched against a decoy database using the MaxQuant software (Version
1.0.13.13) containing normal and reverse sequences of the predicted UniProt
entries of V. cholerae serotype O1 (strain ATCC 39315/El Tor Inaba N16961),
P. aeruginosa (strain ATCC 15692/DSM 22644/CIP 104116/JCM 14847/LMG
12228/1C/PRS 101/PAO1), and A. baylyi (strain ATCC 33305/BD413/ADP1)
(www.ebi.ac.uk, release date 2016/07/19), retention time standard peptides and
commonly observed contaminants (in total 25,934 sequences) generated using the
SequenceReverser tool from the MaxQuant software (Version 1.0.13.13). The
precursor ion tolerance was set to 10 ppm and fragment ion tolerance was set to
0.02 Da. The search criteria were set as follows: full tryptic speciﬁcity was required
(cleavage after lysine or arginine residues unless followed by proline), three missed
cleavages were allowed, carbamidomethylation (C) was set as ﬁxed modiﬁcation.
Heavy-labeled arginine (+10 Da− 13C(6)15N(4)), heavy-labeled lysine (+8 Da−
13C(6)15N(2)) and oxidation (M) were set as a variable modiﬁcations. The resulting
msms.txt ﬁle was converted to a spectral library panel with the 5–10 best transi-
tions for each peptide using an in-house software tool. This was then imported into
the SpectroDive program (Version 8.0, Biognosys, Schlieren, Switzerland) and a
scheduled transition list for quantitative SRM analysis was generated. Here, all
samples were analyzed on a TSQ-Vantage triple-quadrupole mass spectrometer
coupled to an Easy-nLC (Thermo Fisher, Scientiﬁc). In each injection an equivalent
of 1.5 μg of peptides including heavy peptide references was loaded onto a custom-
made main column (Reprosil C18 AQ, 3 μm diameter, 100 Å pore, 0.75 × 300 mm)
and separated using the same gradient mentioned above. The mass spectrometer
was operated in the positive ion mode using ESI with a capillary temperature of
275 °C, a spray voltage of +2200 V. All of the measurements were performed in an
unscheduled mode and a cycle time of 2 s. A 0.7 FWHM resolution window for
both Q1 and Q3 was set for parent-ion and product-ion isolation. Fragmentation of
parent-ions was performed in Q2 at 1.2 mTorr, using collision energies calculated
with the SpectroDive software (version 8.0). Each condition was analyzed in
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biological triplicates. All raw-ﬁles were imported into SpectroDive for absolute
peptide and protein quantiﬁcation. Here, only elution groups with q-values < 0.01
were considered correct calls and used for quantiﬁcation. Median heavy/light ratios
of triplicates were employed to determine protein levels. The absolute abundance of
each protein determined by each peptide was calculated as following: target-to-
reference ratio × spiked in heavy peptide amount × Avogadro’s number/cell num-
ber. Signiﬁcance of different peptide abundances under different conditions was
calculated using p-values from Tukey’s multiple comparison test in Prism
GraphPad 7.04. For the time-course experiment, such tests were performed on the
copy number of each protein under different conditions. For the protein synthesis
inhibition experiment, such test was performed on the relative levels to TssB for
each protein following the treatment. It should be noted that the quantiﬁcation of
VasX was performed using crude peptides, since no quantiﬁed, proteotypic peptide
was available for determining the precise concentration of the heavy peptides used
for VasX.
Reporting summary. Further information on research design is available in
the Nature Research Reporting Summary linked to this article.
Data availability
The mass spectrometry proteomics data have been deposited to the ProteomeXchange
Consortium72 (http://proteomecentral.proteomexchange.org) via the PRIDE partner
repository73 with the dataset identiﬁer PXD012832 [https://www.ebi.ac.uk/pride/archive/
projects/PXD012832]. The source data for Figs. 2b–d, 3a, b, 4a, b, and 5a, b and
Supplementary Figs. 1, 2, 3, 4a, b, and 5 are provided as a Source Data ﬁle. A reporting
summary for this Article is available as a Supplementary Information ﬁle. All other data
supporting the ﬁndings of this study are available from the corresponding author on
reasonable request.
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